---
$id: https://graph.org.ai/products/commodity/51332817
$type: Product
source: UNSPSC
code: "51332817"
title: "Promazine"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Promazine

**UNSPSC Code**: 51332817
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phenothiazine and antipsychotic agent with the molecular formula C17H20N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O9M39HTM5W, chemically known as 10h-phenothiazine-10-propanamine, n,n-dimethyl-, monohydrochloride but generally known as promazine, which bears US NIH Compound Identifier 4926. European Medicines Agency schedules Promazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10085MIG. The term PROMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 1 1998, List 39). World Health Organization schedules promazine in its Anatomical Therapeutic Chemical (ATC) Classification. PROMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule promazine under HS 29343090 and SITC 51578. As of Q4 2014, PROMAZINE remains the US FDA Preferred Term for this commodity. Promazine bears US NLM identifiers UMLS ID C0033399 and NCI Concept Code C61908. SMILES: S1C2C(N(CCCN(C)C)C3C1CCCC3)CCCC2.

